What We Do
Healthcare
The Taruta Healthcare LLP operates as a pharmaceutical company, specializing in the export of high-quality medicines. These medicines are manufactured in plants approved by WHO-GMP and EU-GMP standards. Our export markets include WANA, ASEAN, CIS, and LATAM regions. Our extensive range of pharmaceutical medicines covers various therapeutic areas, such as anti-viral, anti-cancer, anti-HIV, anti-HPV, anti-diabetic, anti-hypertensive, anti-biotic, hormonal drugs, CNS drugs, and nephrology drugs. We also manufacture and market both cosmeceutical and nutraceutical products. We tailor our product packaging to meet the specific regulatory requirements of each country.
Product Development and Testing
We are Taruta Pharma Solutions, a leading partner in CRO/CDMO (Contract Research Organization and Contract Development & Manufacturing Organization). Our mission is to accelerate the journey from ideas to medicines. Our expertise spans drug development, and manufacturing of APIs and formulations. With over two decades of experience, we collaborate with global pharma, biotech, chemical, nutraceutical, and cosmetic clients.
Our comprehensive network covers the entire drug development chain, including global and domestic laboratories, testing units, and high-quality manufacturers. We specialize in sourcing drug substances and raw materials, as well as drug product development. Our goal is to expedite pharmaceutical companies’ progress from the development phase to manufacturing. We take pride in delivering integrated services that compress timelines, thereby accelerating the drug development process.
With our clients’ in-house facilities and our network of development and testing laboratories, we support development initiatives on a versatile scale. Our extensive expertise in drug development and manufacturing ensures that your project is in capable hands.
Manufacturing and Technology Transfer
We facilitate the seamless transition of drug products and their established manufacturing processes from the development phase to commercial production. This process of technology transfer involves moving existing products from one manufacturing site to another due to factors such as facility changes, company mergers, acquisitions, or a shift to a contract manufacturer (CMO). Throughout this transition, we adhere to current regulatory guidelines and ensure that the validated processes maintain the highest quality standards